Using metal nanoparticles to fight SARS-CoV-2

using metal nanoparticles to fight sars cov 2

Sumary of Using metal nanoparticles to fight SARS-CoV-2:

  • A recent review article looks at the potential of nanotechnology in fighting severe acute respiratory syndrome 2 (SARS-CoV-2), with several possibilities of strategies in therapeutics, vaccines, and prevention.
  • The review article, published in the journal Nanomaterials provides insights into recent studies using metal nanocomposites as antivirals.
  • In addition to discussing SARS-CoV, middle east respiratory (MERS)-CoV, and coronaviruses, other enveloped and RNA viruses are also included as targets for metallic nanomaterials in this review.
  • Among these, SARS-CoV, MERS-CoV, and SARS-CoV-2 cause severe respiratory disease with complex pathophysiology associated with multiple organ failure, sepsis, and death.
  • In addition, the fact that the virus uses the host cell machinery for its replication is essential for developing an antiviral drug that does not harm the host.
  • Unique size, high surface-to-volume ratio, surface plasmon resonance, and malleable optical absorption spectra of metallic nanoparticles are some of the advantages in using nanotechnology for antiviral strategies – bioconjugation, nanocarriers or drug stabilization, production of hosts reactive oxygen species (ROS), etc.
  • Viral components are packed and assembly in a mature virion structure that is then released Metal Nanoparticles as Antivirals Related StoriesMetal nanoparticles can attack multiple viral targets with minimal subsequent resistance development.
  • The antiviral and inhibitory activity of AgNPs is shown against TGEV, porcine coronavirus, as a model of CoV and feline coronavirus (FCoV).

Want to know more click here go to source.

From -

Close

Site Language


Popular Posts

745

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close